| Comprehensive guidance for antibiotic dosing in obese adults L Meng, E Mui, MK Holubar, SC Deresinski Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (11 …, 2017 | 148 | 2017 |
| The E7 Oncoprotein of Human Papillomavirus Type 16 Stabilizes p53 through a Mechanism Independent of p19ARF SE Seavey, M Holubar, LJ Saucedo, ME Perry Journal of virology 73 (9), 7590-7598, 1999 | 113 | 1999 |
| Antimicrobial Resistance in Methicillin-Resistant Staphylococcus aureus to Newer Antimicrobial Agents RR Watkins, M Holubar, MZ David Antimicrobial agents and chemotherapy 63 (12), 10.1128/aac. 01216-19, 2019 | 103 | 2019 |
| p76MDM2 inhibits the ability of p90MDM2to destabilize p53 ME Perry, SM Mendrysa, LJ Saucedo, P Tannous, M Holubar Journal of Biological Chemistry 275 (8), 5733-5738, 2000 | 96 | 2000 |
| Conversion from vancomycin trough concentration–guided dosing to area under the curve–guided dosing using two sample measurements in adults: implementation at an academic … L Meng, T Wong, S Huang, E Mui, V Nguyen, G Espinosa, J Desai, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (4 …, 2019 | 86 | 2019 |
| Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity S Chakraborty, JC Gonzalez, BL Sievers, V Mallajosyula, S Chakraborty, ... Science Translational Medicine 14 (635), eabm7853, 2022 | 84 | 2022 |
| Real-time electronic tracking of diarrheal episodes and laxative therapy enables verification of Clostridium difficile clinical testing criteria and reduction of Clostridium … CY Truong, S Gombar, R Wilson, G Sundararajan, N Tekic, M Holubar, ... Journal of clinical microbiology 55 (5), 1276-1284, 2017 | 76 | 2017 |
| Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials LE Taylor, M Holubar, K Wu, RJ Bosch, DL Wyles, JA Davis, KH Mayer, ... Clinical infectious diseases 52 (6), 812-818, 2011 | 68 | 2011 |
| Association of race/ethnicity with likeliness of COVID-19 vaccine uptake among health workers and the general population in the San Francisco Bay Area K Grumbach, T Judson, M Desai, V Jain, C Lindan, SB Doernberg, ... JAMA internal medicine 181 (7), 1008-1011, 2021 | 67 | 2021 |
| Antimicrobial resistance in sexually transmitted infections V Tien, C Punjabi, MK Holubar Journal of travel medicine 27 (1), taz101, 2020 | 66 | 2020 |
| Bacteremia due to methicillin-resistant Staphylococcus aureus: new therapeutic approaches M Holubar, L Meng, S Deresinski Infectious Disease Clinics 30 (2), 491-507, 2016 | 56 | 2016 |
| Oral fluoroquinolone or trimethoprim-sulfamethoxazole vs ß-lactams as step-down therapy for Enterobacteriaceae bacteremia: systematic review and meta-analysis C Punjabi, V Tien, L Meng, S Deresinski, M Holubar Open Forum Infectious Diseases 6 (10), ofz364, 2019 | 55 | 2019 |
| Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication J Guo, S Bolivar-Wagers, N Srinivas, M Holubar, Y Maldonado Vaccine 33 (10), 1235-1242, 2015 | 51 | 2015 |
| Feasibility and applicability of antimicrobial stewardship in immunocompromised patients E Robilotti, M Holubar, SK Seo, S Deresinski Current opinion in infectious diseases 30 (4), 346-353, 2017 | 50 | 2017 |
| Cefiderocol: a new cephalosporin stratagem against multidrug-resistant Gram-negative bacteria S Ong’uti, M Czech, E Robilotti, M Holubar Clinical Infectious Diseases 74 (7), 1303-1312, 2022 | 42 | 2022 |
| Strand-specific reverse transcription PCR for detection of replicating SARS-CoV-2 CA Hogan, CH Huang, MK Sahoo, H Wang, B Jiang, M Sibai, M Holubar, ... Emerging Infectious Diseases 27 (2), 632, 2021 | 37 | 2021 |
| Favipiravir for treatment of outpatients with asymptomatic or uncomplicated coronavirus disease 2019: a double-blind, randomized, placebo-controlled, phase 2 trial M Holubar, A Subramanian, N Purington, H Hedlin, B Bunning, KS Walter, ... Clinical Infectious Diseases 75 (11), 1883-1892, 2022 | 36 | 2022 |
| Post-vaccination SARS-CoV-2 infections and incidence of the B. 1.427/B. 1.429 variant among healthcare personnel at a northern California academic medical center KB Jacobson, BA Pinsky, MEM Rath, H Wang, JA Miller, M Skhiri, ... MedRxiv, 2021 | 34 | 2021 |
| SARS-CoV-2 subgenomic RNA kinetics in longitudinal clinical samples R Verma, E Kim, GJ Martínez-Colón, P Jagannathan, A Rustagi, ... Open forum infectious diseases 8 (7), ofab310, 2021 | 26 | 2021 |
| Impact of rapid antimicrobial susceptibility testing in Gram-negative rod bacteremia: a quasi-experimental study CA Hogan, B Ebunji, N Watz, K Kapphahn, J Rigdon, E Mui, L Meng, ... Journal of Clinical Microbiology 58 (9), 10.1128/jcm. 00360-20, 2020 | 24 | 2020 |
